These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Release reaction of brain-derived neurotrophic factor (BDNF) through PAR1 activation and its two distinct pools in human platelets. Tamura S; Suzuki H; Hirowatari Y; Hatase M; Nagasawa A; Matsuno K; Kobayashi S; Moriyama T Thromb Res; 2011 Nov; 128(5):e55-61. PubMed ID: 21924459 [TBL] [Abstract][Full Text] [Related]
47. Osteonectin is an alpha-granule component involved with thrombospondin in platelet aggregation. Clezardin P; Malaval L; Morel MC; Guichard J; Lecompte T; Trzeciak MC; Dechavanne M; Breton-Gorius J; Delmas PD; Kaplan C J Bone Miner Res; 1991 Oct; 6(10):1059-70. PubMed ID: 1796754 [TBL] [Abstract][Full Text] [Related]
48. Effect of neutrophil adhesion on the size of aggregates formed by agonist-activated platelets. Koda M; Banno Y; Naganawa T Platelets; 2005 Dec; 16(8):482-91. PubMed ID: 16287615 [TBL] [Abstract][Full Text] [Related]
49. Inhibition of agonist-induced platelet aggregation, Ca2+ mobilization and granule secretion by guanosine 5'-[beta-thio]diphosphate and GDP in intact platelets. Evidence for an inhibitory mechanism unrelated to the inhibition of G-protein-GTP interaction. Krishnamurthi S; Patel Y; Kakkar VV Biochem J; 1988 Feb; 250(1):209-14. PubMed ID: 3355512 [TBL] [Abstract][Full Text] [Related]
50. Pharmacologic protein kinase Cα inhibition uncouples human platelet-stimulated angiogenesis from collagen-induced aggregation. Moncada de la Rosa C; Radziwon-Balicka A; El-Sikhry H; Seubert J; Ruvolo PP; Radomski MW; Jurasz P J Pharmacol Exp Ther; 2013 Apr; 345(1):15-24. PubMed ID: 23386249 [TBL] [Abstract][Full Text] [Related]
51. Factor Xa Inhibitor Suppresses the Release of Phosphorylated HSP27 from Collagen-Stimulated Human Platelets: Inhibition of HSP27 Phosphorylation via p44/p42 MAP Kinase. Tsujimoto M; Kuroyanagi G; Matsushima-Nishiwaki R; Kito Y; Enomoto Y; Iida H; Ogura S; Otsuka T; Tokuda H; Kozawa O; Iwama T PLoS One; 2016; 11(2):e0149077. PubMed ID: 26867010 [TBL] [Abstract][Full Text] [Related]
52. Fibroblast heterogeneity in collagenolytic response to cyclosporine. Tipton DA; Stricklin GP; Dabbous MK J Cell Biochem; 1991 Jun; 46(2):152-65. PubMed ID: 1655819 [TBL] [Abstract][Full Text] [Related]
53. Incorporation of a circulating protein into alpha granules of megakaryocytes. Handagama PJ; Bainton DF Blood Cells; 1989; 15(1):59-72. PubMed ID: 2930854 [TBL] [Abstract][Full Text] [Related]
54. Ribonuclease inhibitors in human blood: comparative studies on the inhibitors detected in erythrocytes, platelets, mononuclear leukocytes and granulocytes. Nadano D; Yasuda T; Takeshita H; Kishi K Int J Biochem Cell Biol; 1995 Sep; 27(9):971-9. PubMed ID: 7584633 [TBL] [Abstract][Full Text] [Related]
55. The influence of cell culture variables on human collagenase inhibitor expression. Welgus HG; Brown NL; Stricklin GP Coll Relat Res; 1984 Oct; 4(5):377-88. PubMed ID: 6509892 [TBL] [Abstract][Full Text] [Related]